HCPCS Q0519 is officially defined as "Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days." No tracked policy changes reference HCPCS Q0519 yet. New payer updates are added daily, so check back soon or create a free alert to be notified the moment a change affects this code.
No tracked policy changes match this filter yet. New policies are added daily.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.